$13.46 +0.04 (0.30%)
Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| $0.11 | 2003-08-07 | 2003-08-11 | |
| August 6, 2025 | $0.09 | 2025-07-25 | 2025-07-10 |
| August 12, 2024 | $0.48 | 2024-07-30 | 2024-07-15 |
| August 11, 2023 | $0.48 | 2023-07-28 | 2023-07-10 |
| August 12, 2022 | $0.38 | 2022-08-01 | 2022-07-11 |
Dividends Summary
- The most recent dividend was paid 90 days ago, on August 6, 2025
- The highest dividend payed out to investors during this period was $0.48 per share
- The average dividend paid during this period was $0.24 per share.
Company News
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
The Trump administration will exclude imported generic drugs from potential tariffs, bringing relief to pharmaceutical companies and Indian drugmakers who supply nearly half of U.S. generic prescriptions.
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040
Esperion has settled patent litigation with Dr. Reddy's Laboratories, agreeing that generic versions of NEXLETOL and NEXLIZET will not be marketed in the US before April 19, 2040.
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP 500 million to boost its OTC presence worldwide.
The success of Merck's antiviral — and other COVID-19 pills in development — may depend on how quickly people start taking them
That may mean starting treatment within days after testing positive for the virus.